Disease | drug rash with eosinophilia and systemic symptoms |
Symptom | C0014457|eosinophilia |
Sentences | 16 |
PubMedID- 23216243 | Pustular-type drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to carbamazepine with systemic muscle involvement. |
PubMedID- 23182063 | Background: drug-induced hypersensitivity syndrome (dihs)/drug reaction with eosinophilia and systemic symptoms (dress) is a severe systemic hypersensitivity reaction caused by specific drugs, in which herpesvirus reactivations and organ dysfunction occur during the course of the disease. |
PubMedID- 24749495 | Background: drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms (dihs/dress) and stevens-johnson syndrome (sjs)/toxic epidermal necrolysis (ten) represent contrasting poles of severe drug eruptions, and sequential reactivations of several herpesviruses have exclusively been demonstrated in the former. |
PubMedID- 19874350 | Background: drug-induced hypersensitivity syndrome (dihs)/drug rash with eosinophilia and systemic symptoms (dress) syndrome is characterized by late disease onset, fever, rash, hepatic dysfunction, haematological abnormalities, lymphadenopathy and often, human herpesvirus (hhv) reactivation. |
PubMedID- 24903194 | The serum level of hmgb1 (high mobility group box 1 protein) is preferentially high in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. |
PubMedID- 24635062 | Increased ratio of foxp3+ regulatory t cells/cd3+ t cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms. |
PubMedID- 22666603 | Symptoms of hsr can range from general manifestations, such as morbiliform rash, urticaria, angioedema, fever, malaise, anaphylaxis, bronchospasm, and erythema multiforme, to severe cutaneous adverse reactions (scar) such as drug-induced hypersensitivity syndrome (dihs)/drug reaction with eosinophilia and systemic symptoms (dress), and stevens-johnson syndrome (sjs)/toxic epidermal necrolysis (ten) . |
PubMedID- 22380544 | drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms syndrome induced by cilostazol and carbamazepine. |
PubMedID- 25623158 | drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (dihs/dress) is a severe adverse drug reaction caused by specific drug. |
PubMedID- 22739739 | drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (dihs/dress) is a severe drug-induced adverse reaction that in most cases occurs 3 to 6 weeks after drug administration . |
PubMedID- 25156337 | drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms with histologic features mimicking cutaneous pseudolymphoma. |
PubMedID- 24517870 | Tnf-alpha as a useful predictor of human herpesvirus-6 reactivation and indicator of the disease process in drug-induced hypersensitivity syndrome (dihs)/drug reaction with eosinophilia and systemic symptoms (dress). |
PubMedID- 26110678 | Purpose of review: severe adverse drug reactions (adrs) including stevens-johnson syndrome (sjs)/toxic epidermal necrolysis (ten) and drug-induced hypersensitivity syndrome (dihs)/drug reaction with eosinophilia and systemic symptoms (dress) are acute life-threatening conditions. |
PubMedID- 20861604 | The hhv-7 reactivation might be related to facial pustulosis, which is occasionally observed in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms. |
PubMedID- 25547780 | Differential expression profile of th1/th2-associated chemokines characterizes stevens-johnson syndrome/toxic epidermal necrolysis (sjs/ten) and drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (dihs/dress) as distinct entities. |
PubMedID- 23141052 | Background: drug-induced hypersensitivity syndrome (dihs)/drug rash with eosinophilia and systemic symptoms (dress) is a serious acute drug reaction with fever, cutaneous eruption, lymphadenopathy, and several visceral dysfunctions. |
Page: 1